Search bioRxiv⌕ Search

Biology subjects

Bianchini, M.

Publications and source records attributed to Bianchini, M..

2 recordsLinked to original sources

Graph-based integration of histone modifications profiles: haematopoietic cell differentiation as a case study

In this paper, we show that quantifying histone modifications by counting the number of high- resolution peaks in each gene allows to build profiles of these epigenetic marks, associating them to a phenotype. The significance of this approach is verified by applying graph-cut techniques for assessing the differentiation between myeloid and lymphoid cells in haematopoiesis, i.e. the process through which all the different types of blood cells originate starting from a unique cell type. The experiments are conducted on a population of samples from 24 cell types involved in haematopoiesis. Six profiles are constructed for each cell type, based on a different histone modification signal. Following the experimentally verified idea that the peak number distribution per gene behaves similarly to gene expression, the profile computation employs standard differential analysis tools to find genes whose epigenetic modifications are related to a given phenotype. Next, six similarity networks of cell types are constructed, based on each histone modification, and then combined into a unique one through similarity network fusion. Finally, the similarity networks are transformed into dissimilarity graphs, to which two different cuts are applied and compared to evaluate the classic differentiation between myeloid and lymphoid cells. The results show that all histone modifications contribute almost equally to the myeloid/lymphoid differentiation, and this is also confirmed by the analysis of the fused network. However, they also suggest that histone modifications may not be the only mechanism for regulating the differentiation of hematopoietic cells.

bioinformatics↗

miRNome profiling of clonal stem cells in Ph+ CML

Chronic myeloid leukemia (CML) is a myeloid stem cell neoplasm characterized by an expansion of myeloid progenitor cells and the presence of BCR-ABL1 oncoprotein. Since the introduction of specific BCR-ABL1 tyrosine kinase inhibitors (TKI), overall survival has improved significantly. However, under long-term therapy patients may have residual disease that originates from TKI-resistant leukemic stem cells (LSC). In this work, we analyzed the miRNome of CML LSC, normal hematopoietic stem cells (HSC) obtained from the same CML patients, and stem and progenitor cells obtained from healthy donors (HD) by next-generation sequencing. We detected a global decrease of microRNA levels in LSC and HSC from CML patients, and decreased levels of microRNAs and snoRNAs from a genomic cluster in chromosome 14, suggesting a mechanism of silencing of multiple non-coding RNAs. Surprisingly, HSC from CML patients, despite the absence of BCR-ABL1 expression, showed an altered miRNome. In silico analysis revealed an association between validated microRNAs and multiple metabolic pathways, suggesting that these molecules may be mediators of the previously reported dysregulation of LSC metabolism. This is the first report of the LSC miRNome that distinguishes between BCR-ABL1+ LSC and their BCR-ABL1- counterparts, providing valuable data for future studies.

cancer biology↗